{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"nad-plus-trigeminal","title":"NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models","body":"## What's breaking down\n\nTrigeminal neuralgia involves sudden, severe facial pain from issues with the trigeminal nerve. Common layers include neurovascular compression causing nerve root distortion or atrophy, demyelination of afferents, elevated oxidative stress, and mitochondrial impairment in the trigeminal ganglion. These create hyperexcitability through altered ion channels and inflammatory signaling. Breakdown outruns natural repair when mitochondrial energy production drops, sustaining ectopic firing and sensitization.\n\n## Why NAD+ might help you\n\nNAD+ supports cellular energy production inside mitochondria. In the trigeminal ganglion, mitochondrial defects lower NAD+ levels and NAD+/NADH ratios, impairing the electron transport chain.\n\n1. If mitochondrial dysfunction sits in your pain pathway, boosting NAD+ with precursors like NR replenishes the pool.\n2. Restored NAD+ activates Sirt1, which downregulates pain-related genes and inflammatory pathways.\n3. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — NAD+ targets the cellular energy layer in trigeminal ganglion neurons.\n\n## What the evidence actually shows\n\nA 2025 mouse study used chronic constriction injury of the infraorbital nerve (CCI-IoN) to model trigeminal neuropathic pain. Researchers performed RNA-seq on the trigeminal ganglion and found broad downregulation of mitochondrial genes plus reduced NAD+ levels. NR supplementation raised NAD+, improved mitochondrial fitness, reduced mechanical allodynia, and worked mainly through Sirt1 to suppress inflammation and pain genes. This is preclinical (animal model) evidence only. No human trials specific to NAD+ or NR for trigeminal neuralgia appear in current searches. Broader reviews link NAD+ decline to mitochondrial dysfunction and oxidative stress in peripheral neuropathic pain, but again at mechanistic and animal levels.\n\n## What scientists say\n\nThe study authors conclude that targeting mitochondrial dysfunction via NAD+ replenishment offers a novel approach to craniofacial pain. They note the analgesic effect of NR depends on Sirt1 and involves downregulation of ion channels like HCN2 and inflammatory pathways. Human data on NAD+ restoration for nerve pain remain absent; ongoing work explores NAD+ in other neuropathic conditions through mitochondrial mechanisms.\n\n## What people say on Reddit\n\nAnecdotal reports appear in trigeminal neuralgia and related subreddits. Users mention trying NAD+ or B3 forms for energy during pain flares or alongside other approaches, with mixed comments on perceived benefits for fatigue rather than direct pain relief. One post links NAD+ discussion to B12 in a “double whammy” pain thread. These remain individual experiences without controlled reporting.\n\n## What people say on X\n\nLimited public posts tie NAD+ specifically to trigeminal issues. Mentions are sparse and mostly general energy or supplement discussions overlapping with neuropathic pain communities.\n\n## What we do not know\n\nNo published human trials test NAD+ precursors for trigeminal neuralgia. Long-term effects on nerve repair in humans, optimal delivery methods, and interactions with common TN medications are unknown. Translation from mouse CCI-IoN models to classical TN with vascular compression requires further study.\n\n## Safety and limits\n\nAnimal studies report NAD+ precursor use without major adverse signals in the cited model. Human safety data for NAD+ boosting come from other contexts and show generally good tolerability at studied doses, though individual responses vary. This remains an area of active research without established clinical protocols for this condition.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/nad-plus-trigeminal/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"A 2025 mouse study (CCI-IoN model) found mitochondrial gene downregulation and reduced NAD+ in the trigeminal ganglion; NR supplementation improved mitochondrial function, activated Sirt1, downregulated pain and inflammatory genes, and reduced mechanical allodynia.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Direct evidence linking NAD+ restoration to trigeminal neuropathic pain relief in an animal model of nerve injury.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human clinical trials specifically testing NAD+ or NR for trigeminal neuralgia were identified in searches of PubMed and related databases.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the gap between animal data and clinical application for this exact use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Reddit users in trigeminal neuralgia communities report personal experimentation with NAD+ or B3 forms, often noting effects on energy rather than direct pain resolution.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s3"],"source_status":"sourced","why_material":"Captures real-world user reports separate from controlled evidence.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39528053/","title":"Restoration of mitochondrial function alleviates trigeminal neuropathic pain in mice","quote":"Our findings demonstrated that rejuvenating mitochondria by boosting NAD + levels enhanced mitochondrial fitness and significantly ameliorated trigeminal neuropathic pain.","summary":"2025 mouse study using NR in CCI-IoN model; shows mitochondrial defects, NAD+ depletion, and NR benefits via Sirt1.","claim_ids":["c1","c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:39:57.120Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"814308762fa2ca7bf8b4cba44bc363a0c99e34c365466392f5394eac6529661f"},{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/TrigeminalNeuralgia/comments/193maap/double_whammy/","title":"Double Whammy","quote":"B12 and B3( NAD +) especially.","summary":"User mention of NAD+ in context of trigeminal neuralgia pain management discussion.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:39:57.120Z","link_status":"ok","quote_status":"unverified","prev":"814308762fa2ca7bf8b4cba44bc363a0c99e34c365466392f5394eac6529661f","hash":"fb74fd23b52fb405cf11d5d4e054d20caf5c3174749d9b03c22c9df2a96d9ab3"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:39:58.363Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models","register":"source_ledger","body":"## What's breaking down\n\nTrigeminal neuralgia involves sudden, severe facial pain from issues with the trigeminal nerve. Common layers include neurovascular compression causing nerve root distortion or atrophy, demyelination of afferents, elevated oxidative stress, and mitochondrial impairment in the trigeminal ganglion. These create hyperexcitability through altered ion channels and inflammatory signaling. Breakdown outruns natural repair when mitochondrial energy production drops, sustaining ectopic firing and sensitization.\n\n## Why NAD+ might help you\n\nNAD+ supports cellular energy production inside mitochondria. In the trigeminal ganglion, mitochondrial defects lower NAD+ levels and NAD+/NADH ratios, impairing the electron transport chain.\n\n1. If mitochondrial dysfunction sits in your pain pathway, boosting NAD+ with precursors like NR replenishes the pool.\n2. Restored NAD+ activates Sirt1, which downregulates pain-related genes and inflammatory pathways.\n3. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — NAD+ targets the cellular energy layer in trigeminal ganglion neurons.\n\n## What the evidence actually shows\n\nA 2025 mouse study used chronic constriction injury of the infraorbital nerve (CCI-IoN) to model trigeminal neuropathic pain. Researchers performed RNA-seq on the trigeminal ganglion and found broad downregulation of mitochondrial genes plus reduced NAD+ levels. NR supplementation raised NAD+, improved mitochondrial fitness, reduced mechanical allodynia, and worked mainly through Sirt1 to suppress inflammation and pain genes. This is preclinical (animal model) evidence only. No human trials specific to NAD+ or NR for trigeminal neuralgia appear in current searches. Broader reviews link NAD+ decline to mitochondrial dysfunction and oxidative stress in peripheral neuropathic pain, but again at mechanistic and animal levels.\n\n## What scientists say\n\nThe study authors conclude that targeting mitochondrial dysfunction via NAD+ replenishment offers a novel approach to craniofacial pain. They note the analgesic effect of NR depends on Sirt1 and involves downregulation of ion channels like HCN2 and inflammatory pathways. Human data on NAD+ restoration for nerve pain remain absent; ongoing work explores NAD+ in other neuropathic conditions through mitochondrial mechanisms.\n\n## What people say on Reddit\n\nAnecdotal reports appear in trigeminal neuralgia and related subreddits. Users mention trying NAD+ or B3 forms for energy during pain flares or alongside other approaches, with mixed comments on perceived benefits for fatigue rather than direct pain relief. One post links NAD+ discussion to B12 in a “double whammy” pain thread. These remain individual experiences without controlled reporting.\n\n## What people say on X\n\nLimited public posts tie NAD+ specifically to trigeminal issues. Mentions are sparse and mostly general energy or supplement discussions overlapping with neuropathic pain communities.\n\n## What we do not know\n\nNo published human trials test NAD+ precursors for trigeminal neuralgia. Long-term effects on nerve repair in humans, optimal delivery methods, and interactions with common TN medications are unknown. Translation from mouse CCI-IoN models to classical TN with vascular compression requires further study.\n\n## Safety and limits\n\nAnimal studies report NAD+ precursor use without major adverse signals in the cited model. Human safety data for NAD+ boosting come from other contexts and show generally good tolerability at studied doses, though individual responses vary. This remains an area of active research without established clinical protocols for this condition.","claims":[{"id":"c1","text":"A 2025 mouse study (CCI-IoN model) found mitochondrial gene downregulation and reduced NAD+ in the trigeminal ganglion; NR supplementation improved mitochondrial function, activated Sirt1, downregulated pain and inflammatory genes, and reduced mechanical allodynia.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Direct evidence linking NAD+ restoration to trigeminal neuropathic pain relief in an animal model of nerve injury.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human clinical trials specifically testing NAD+ or NR for trigeminal neuralgia were identified in searches of PubMed and related databases.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the gap between animal data and clinical application for this exact use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Reddit users in trigeminal neuralgia communities report personal experimentation with NAD+ or B3 forms, often noting effects on energy rather than direct pain resolution.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s3"],"source_status":"sourced","why_material":"Captures real-world user reports separate from controlled evidence.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39528053/","title":"Restoration of mitochondrial function alleviates trigeminal neuropathic pain in mice","quote":"Our findings demonstrated that rejuvenating mitochondria by boosting NAD + levels enhanced mitochondrial fitness and significantly ameliorated trigeminal neuropathic pain.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/TrigeminalNeuralgia/comments/193maap/double_whammy/","title":"Double Whammy","quote":"B12 and B3( NAD +) especially.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":30620,"tokens_out":2247,"cost":0.0438925,"prev_hash":"genesis","hash":"89c98bda1f579ed714f6ae911c8b9209dc8f0ebce4732b30bb09111a6066de97"}],"provenance":[{"ts":"2026-06-30T01:39:58.363Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: NAD Plus for Trigeminal\nSlug: nad-plus-trigeminal\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"nad-plus\",\"name\":\"NAD+\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"nad-plus\",\"name\":\"NAD+\",\"section_title\":\"Why NAD+ might help you\",\"layer\":\"cellular energy\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **NAD+** → cellular energy\",\"section_headings\":[\"What's breaking down\",\"Why NAD+ might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / dr","response":"{\n  \"slug\": \"nad-plus-trigeminal\",\n  \"title\": \"NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models\",\n  \"body\": \"## What's breaking down\\n\\nTrigeminal neuralgia involves sudden, severe facial pain from issues with the trigeminal nerve. Common layers include neurovascular compression causing nerve root distortion or atrophy, demyelination of afferents, elevated oxidative stress, and mitochondrial impairment in the trigeminal ganglion. These create hyperexcitability through altered ion channels and inflammatory signaling. Breakdown outruns natural repair when mitochondrial energy production drops, sustaining ectopic firing and sensitization.\\n\\n## Why NAD+ might help you\\n\\nNAD+ supports cellular energy production inside mitochondria. In the trigeminal ganglion, mitochondrial defects lower NAD+ levels and NAD+/NADH ratios, impairing the electron transport chain.\\n\\n1. If mitochondrial dysfunction sits in your pain pathway, boosting NAD+ with precursors like NR replenishes the pool.\\n2. Restored NAD+ activates Sirt1, which downregulates pain-related genes and inflammatory pathways.\\n3. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\\n\\n## How these fit together\\n\\nSingle-compound focus — NAD+ targets the cellular energy layer in trigeminal ganglion neurons.\\n\\n## What the evidence actually shows\\n\\nA 2025 mouse study used chronic constriction injury of the infraorbital nerve (CCI-IoN) to model trigeminal neuropathic pain. Researchers performed RNA-seq on the trigeminal ganglion and found broad downregulation of mitochondrial genes plus reduced NAD+ levels. NR supplementation raised NAD+, improved mitochondrial fitness, reduced mechanical allodynia, and worked mainly through Sirt1 to suppress inflammation and pain genes. This is preclinical (animal model) evidence only. No human trials specific to NAD+ or NR for trigeminal neuralgia appear in current searches. Broader r","tokens_in":30620,"tokens_out":2247,"cost":0,"prev":"genesis","hash":"62cd9027ac8c9b2469fb0a9847ba6d17c67212f19a664f39703aafa3584164ee"},{"ts":"2026-07-17T02:40:45.652Z","model":"owner","action":"voxel_divide","prompt":"","input":"nad-plus-trigeminal","response":"19 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"62cd9027ac8c9b2469fb0a9847ba6d17c67212f19a664f39703aafa3584164ee","hash":"ffd5ec51ec323b92f221ad9fa30e2cc8aeb7ad549b41987c831613386d9a999b"}],"energy":{"passes":2,"tokens_in":30620,"tokens_out":2247,"tokens_total":32867,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"ffd5ec51ec323b92f221ad9fa30e2cc8aeb7ad549b41987c831613386d9a999b"},"posted_at":"2026-06-29T21:32:45.179Z","created_at":"2026-06-29T21:32:45.179Z","updated_at":"2026-07-17T02:40:45.652Z","machine":{"shape":"article.machine/v1","slug":"nad-plus-trigeminal","kind":"article","read":{"human":"https://miscsubjects.com/a/nad-plus-trigeminal","json":"https://miscsubjects.com/api/articles/nad-plus-trigeminal","bundle":"https://miscsubjects.com/api/articles/nad-plus-trigeminal/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":3,"sources":2,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/nad-plus-trigeminal/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=nad-plus-trigeminal","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"nad-plus-trigeminal\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"nad-plus-trigeminal\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/nad-plus-trigeminal/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"nad-plus-trigeminal\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/nad-plus-trigeminal | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/nad-plus-trigeminal","json":"/api/articles/nad-plus-trigeminal","markdown":"/api/articles/nad-plus-trigeminal/bundle?format=markdown","skill":"/api/articles/nad-plus-trigeminal/skill","topology":"/api/articles/nad-plus-trigeminal/topology","versions":"/api/articles/nad-plus-trigeminal/revisions","invocations":"/api/articles/nad-plus-trigeminal/invocations"},"editorial_review":null,"editorial_audit":{"slug":"nad-plus-trigeminal","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"961a7effb4cabacb17fe5642dee0a99660fdba2f47b4bf33d6573e9381eefcab","object":{"object_type":"article-object","identity":{"id":"article:nad-plus-trigeminal","slug":"nad-plus-trigeminal","title":"NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/nad-plus-trigeminal","role":"explain","audience":"human"},"skill":{"route":"/api/articles/nad-plus-trigeminal/skill","role":"direct behavior","audience":"model","content":"---\nname: nad-plus-trigeminal\ndescription: Apply the NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models\n\nThis Skill is the behavioral expression of [the canonical article](/a/nad-plus-trigeminal). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/nad-plus-trigeminal.\n- Read claims and relationships at /api/articles/nad-plus-trigeminal/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Trigeminal neuralgia involves sudden, severe facial pain from issues with the trigeminal nerve. Common layers include neurovascular compression causing nerve root distortion or atrophy, demyelination of afferents, eleva\n\n## Representations\n\n- Human: /a/nad-plus-trigeminal\n- JSON: /api/articles/nad-plus-trigeminal\n- Relationships: /api/articles/nad-plus-trigeminal/topology\n- History: /api/articles/nad-plus-trigeminal/revisions\n"},"json":{"route":"/api/articles/nad-plus-trigeminal","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/nad-plus-trigeminal/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","nad","plus","trigeminal"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/nad-plus-trigeminal/invocations?status=success","failure_events":"/api/articles/nad-plus-trigeminal/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"nad-plus-trigeminal","title":"NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models","body":"## What's breaking down\n\nTrigeminal neuralgia involves sudden, severe facial pain from issues with the trigeminal nerve. Common layers include neurovascular compression causing nerve root distortion or atrophy, demyelination of afferents, elevated oxidative stress, and mitochondrial impairment in the trigeminal ganglion. These create hyperexcitability through altered ion channels and inflammatory signaling. Breakdown outruns natural repair when mitochondrial energy production drops, sustaining ectopic firing and sensitization.\n\n## Why NAD+ might help you\n\nNAD+ supports cellular energy production inside mitochondria. In the trigeminal ganglion, mitochondrial defects lower NAD+ levels and NAD+/NADH ratios, impairing the electron transport chain.\n\n1. If mitochondrial dysfunction sits in your pain pathway, boosting NAD+ with precursors like NR replenishes the pool.\n2. Restored NAD+ activates Sirt1, which downregulates pain-related genes and inflammatory pathways.\n3. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — NAD+ targets the cellular energy layer in trigeminal ganglion neurons.\n\n## What the evidence actually shows\n\nA 2025 mouse study used chronic constriction injury of the infraorbital nerve (CCI-IoN) to model trigeminal neuropathic pain. Researchers performed RNA-seq on the trigeminal ganglion and found broad downregulation of mitochondrial genes plus reduced NAD+ levels. NR supplementation raised NAD+, improved mitochondrial fitness, reduced mechanical allodynia, and worked mainly through Sirt1 to suppress inflammation and pain genes. This is preclinical (animal model) evidence only. No human trials specific to NAD+ or NR for trigeminal neuralgia appear in current searches. Broader reviews link NAD+ decline to mitochondrial dysfunction and oxidative stress in peripheral neuropathic pain, but again at mechanistic and animal levels.\n\n## What scientists say\n\nThe study authors conclude that targeting mitochondrial dysfunction via NAD+ replenishment offers a novel approach to craniofacial pain. They note the analgesic effect of NR depends on Sirt1 and involves downregulation of ion channels like HCN2 and inflammatory pathways. Human data on NAD+ restoration for nerve pain remain absent; ongoing work explores NAD+ in other neuropathic conditions through mitochondrial mechanisms.\n\n## What people say on Reddit\n\nAnecdotal reports appear in trigeminal neuralgia and related subreddits. Users mention trying NAD+ or B3 forms for energy during pain flares or alongside other approaches, with mixed comments on perceived benefits for fatigue rather than direct pain relief. One post links NAD+ discussion to B12 in a “double whammy” pain thread. These remain individual experiences without controlled reporting.\n\n## What people say on X\n\nLimited public posts tie NAD+ specifically to trigeminal issues. Mentions are sparse and mostly general energy or supplement discussions overlapping with neuropathic pain communities.\n\n## What we do not know\n\nNo published human trials test NAD+ precursors for trigeminal neuralgia. Long-term effects on nerve repair in humans, optimal delivery methods, and interactions with common TN medications are unknown. Translation from mouse CCI-IoN models to classical TN with vascular compression requires further study.\n\n## Safety and limits\n\nAnimal studies report NAD+ precursor use without major adverse signals in the cited model. Human safety data for NAD+ boosting come from other contexts and show generally good tolerability at studied doses, though individual responses vary. This remains an area of active research without established clinical protocols for this condition.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/nad-plus-trigeminal/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"A 2025 mouse study (CCI-IoN model) found mitochondrial gene downregulation and reduced NAD+ in the trigeminal ganglion; NR supplementation improved mitochondrial function, activated Sirt1, downregulated pain and inflammatory genes, and reduced mechanical allodynia.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Direct evidence linking NAD+ restoration to trigeminal neuropathic pain relief in an animal model of nerve injury.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human clinical trials specifically testing NAD+ or NR for trigeminal neuralgia were identified in searches of PubMed and related databases.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the gap between animal data and clinical application for this exact use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Reddit users in trigeminal neuralgia communities report personal experimentation with NAD+ or B3 forms, often noting effects on energy rather than direct pain resolution.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s3"],"source_status":"sourced","why_material":"Captures real-world user reports separate from controlled evidence.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39528053/","title":"Restoration of mitochondrial function alleviates trigeminal neuropathic pain in mice","quote":"Our findings demonstrated that rejuvenating mitochondria by boosting NAD + levels enhanced mitochondrial fitness and significantly ameliorated trigeminal neuropathic pain.","summary":"2025 mouse study using NR in CCI-IoN model; shows mitochondrial defects, NAD+ depletion, and NR benefits via Sirt1.","claim_ids":["c1","c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:39:57.120Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"814308762fa2ca7bf8b4cba44bc363a0c99e34c365466392f5394eac6529661f"},{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/TrigeminalNeuralgia/comments/193maap/double_whammy/","title":"Double Whammy","quote":"B12 and B3( NAD +) especially.","summary":"User mention of NAD+ in context of trigeminal neuralgia pain management discussion.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:39:57.120Z","link_status":"ok","quote_status":"unverified","prev":"814308762fa2ca7bf8b4cba44bc363a0c99e34c365466392f5394eac6529661f","hash":"fb74fd23b52fb405cf11d5d4e054d20caf5c3174749d9b03c22c9df2a96d9ab3"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:39:58.363Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models","register":"source_ledger","body":"## What's breaking down\n\nTrigeminal neuralgia involves sudden, severe facial pain from issues with the trigeminal nerve. Common layers include neurovascular compression causing nerve root distortion or atrophy, demyelination of afferents, elevated oxidative stress, and mitochondrial impairment in the trigeminal ganglion. These create hyperexcitability through altered ion channels and inflammatory signaling. Breakdown outruns natural repair when mitochondrial energy production drops, sustaining ectopic firing and sensitization.\n\n## Why NAD+ might help you\n\nNAD+ supports cellular energy production inside mitochondria. In the trigeminal ganglion, mitochondrial defects lower NAD+ levels and NAD+/NADH ratios, impairing the electron transport chain.\n\n1. If mitochondrial dysfunction sits in your pain pathway, boosting NAD+ with precursors like NR replenishes the pool.\n2. Restored NAD+ activates Sirt1, which downregulates pain-related genes and inflammatory pathways.\n3. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — NAD+ targets the cellular energy layer in trigeminal ganglion neurons.\n\n## What the evidence actually shows\n\nA 2025 mouse study used chronic constriction injury of the infraorbital nerve (CCI-IoN) to model trigeminal neuropathic pain. Researchers performed RNA-seq on the trigeminal ganglion and found broad downregulation of mitochondrial genes plus reduced NAD+ levels. NR supplementation raised NAD+, improved mitochondrial fitness, reduced mechanical allodynia, and worked mainly through Sirt1 to suppress inflammation and pain genes. This is preclinical (animal model) evidence only. No human trials specific to NAD+ or NR for trigeminal neuralgia appear in current searches. Broader reviews link NAD+ decline to mitochondrial dysfunction and oxidative stress in peripheral neuropathic pain, but again at mechanistic and animal levels.\n\n## What scientists say\n\nThe study authors conclude that targeting mitochondrial dysfunction via NAD+ replenishment offers a novel approach to craniofacial pain. They note the analgesic effect of NR depends on Sirt1 and involves downregulation of ion channels like HCN2 and inflammatory pathways. Human data on NAD+ restoration for nerve pain remain absent; ongoing work explores NAD+ in other neuropathic conditions through mitochondrial mechanisms.\n\n## What people say on Reddit\n\nAnecdotal reports appear in trigeminal neuralgia and related subreddits. Users mention trying NAD+ or B3 forms for energy during pain flares or alongside other approaches, with mixed comments on perceived benefits for fatigue rather than direct pain relief. One post links NAD+ discussion to B12 in a “double whammy” pain thread. These remain individual experiences without controlled reporting.\n\n## What people say on X\n\nLimited public posts tie NAD+ specifically to trigeminal issues. Mentions are sparse and mostly general energy or supplement discussions overlapping with neuropathic pain communities.\n\n## What we do not know\n\nNo published human trials test NAD+ precursors for trigeminal neuralgia. Long-term effects on nerve repair in humans, optimal delivery methods, and interactions with common TN medications are unknown. Translation from mouse CCI-IoN models to classical TN with vascular compression requires further study.\n\n## Safety and limits\n\nAnimal studies report NAD+ precursor use without major adverse signals in the cited model. Human safety data for NAD+ boosting come from other contexts and show generally good tolerability at studied doses, though individual responses vary. This remains an area of active research without established clinical protocols for this condition.","claims":[{"id":"c1","text":"A 2025 mouse study (CCI-IoN model) found mitochondrial gene downregulation and reduced NAD+ in the trigeminal ganglion; NR supplementation improved mitochondrial function, activated Sirt1, downregulated pain and inflammatory genes, and reduced mechanical allodynia.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Direct evidence linking NAD+ restoration to trigeminal neuropathic pain relief in an animal model of nerve injury.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human clinical trials specifically testing NAD+ or NR for trigeminal neuralgia were identified in searches of PubMed and related databases.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the gap between animal data and clinical application for this exact use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Reddit users in trigeminal neuralgia communities report personal experimentation with NAD+ or B3 forms, often noting effects on energy rather than direct pain resolution.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s3"],"source_status":"sourced","why_material":"Captures real-world user reports separate from controlled evidence.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39528053/","title":"Restoration of mitochondrial function alleviates trigeminal neuropathic pain in mice","quote":"Our findings demonstrated that rejuvenating mitochondria by boosting NAD + levels enhanced mitochondrial fitness and significantly ameliorated trigeminal neuropathic pain.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/TrigeminalNeuralgia/comments/193maap/double_whammy/","title":"Double Whammy","quote":"B12 and B3( NAD +) especially.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":30620,"tokens_out":2247,"cost":0.0438925,"prev_hash":"genesis","hash":"89c98bda1f579ed714f6ae911c8b9209dc8f0ebce4732b30bb09111a6066de97"}],"provenance":[{"ts":"2026-06-30T01:39:58.363Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: NAD Plus for Trigeminal\nSlug: nad-plus-trigeminal\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"nad-plus\",\"name\":\"NAD+\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"nad-plus\",\"name\":\"NAD+\",\"section_title\":\"Why NAD+ might help you\",\"layer\":\"cellular energy\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **NAD+** → cellular energy\",\"section_headings\":[\"What's breaking down\",\"Why NAD+ might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / dr","response":"{\n  \"slug\": \"nad-plus-trigeminal\",\n  \"title\": \"NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models\",\n  \"body\": \"## What's breaking down\\n\\nTrigeminal neuralgia involves sudden, severe facial pain from issues with the trigeminal nerve. Common layers include neurovascular compression causing nerve root distortion or atrophy, demyelination of afferents, elevated oxidative stress, and mitochondrial impairment in the trigeminal ganglion. These create hyperexcitability through altered ion channels and inflammatory signaling. Breakdown outruns natural repair when mitochondrial energy production drops, sustaining ectopic firing and sensitization.\\n\\n## Why NAD+ might help you\\n\\nNAD+ supports cellular energy production inside mitochondria. In the trigeminal ganglion, mitochondrial defects lower NAD+ levels and NAD+/NADH ratios, impairing the electron transport chain.\\n\\n1. If mitochondrial dysfunction sits in your pain pathway, boosting NAD+ with precursors like NR replenishes the pool.\\n2. Restored NAD+ activates Sirt1, which downregulates pain-related genes and inflammatory pathways.\\n3. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\\n\\n## How these fit together\\n\\nSingle-compound focus — NAD+ targets the cellular energy layer in trigeminal ganglion neurons.\\n\\n## What the evidence actually shows\\n\\nA 2025 mouse study used chronic constriction injury of the infraorbital nerve (CCI-IoN) to model trigeminal neuropathic pain. Researchers performed RNA-seq on the trigeminal ganglion and found broad downregulation of mitochondrial genes plus reduced NAD+ levels. NR supplementation raised NAD+, improved mitochondrial fitness, reduced mechanical allodynia, and worked mainly through Sirt1 to suppress inflammation and pain genes. This is preclinical (animal model) evidence only. No human trials specific to NAD+ or NR for trigeminal neuralgia appear in current searches. Broader r","tokens_in":30620,"tokens_out":2247,"cost":0,"prev":"genesis","hash":"62cd9027ac8c9b2469fb0a9847ba6d17c67212f19a664f39703aafa3584164ee"},{"ts":"2026-07-17T02:40:45.652Z","model":"owner","action":"voxel_divide","prompt":"","input":"nad-plus-trigeminal","response":"19 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"62cd9027ac8c9b2469fb0a9847ba6d17c67212f19a664f39703aafa3584164ee","hash":"ffd5ec51ec323b92f221ad9fa30e2cc8aeb7ad549b41987c831613386d9a999b"}],"energy":{"passes":2,"tokens_in":30620,"tokens_out":2247,"tokens_total":32867,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"ffd5ec51ec323b92f221ad9fa30e2cc8aeb7ad549b41987c831613386d9a999b"},"posted_at":"2026-06-29T21:32:45.179Z","created_at":"2026-06-29T21:32:45.179Z","updated_at":"2026-07-17T02:40:45.652Z","machine":{"shape":"article.machine/v1","slug":"nad-plus-trigeminal","kind":"article","read":{"human":"https://miscsubjects.com/a/nad-plus-trigeminal","json":"https://miscsubjects.com/api/articles/nad-plus-trigeminal","bundle":"https://miscsubjects.com/api/articles/nad-plus-trigeminal/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":3,"sources":2,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/nad-plus-trigeminal/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=nad-plus-trigeminal","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"nad-plus-trigeminal\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"nad-plus-trigeminal\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/nad-plus-trigeminal/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"nad-plus-trigeminal\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/nad-plus-trigeminal | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/nad-plus-trigeminal","json":"/api/articles/nad-plus-trigeminal","markdown":"/api/articles/nad-plus-trigeminal/bundle?format=markdown","skill":"/api/articles/nad-plus-trigeminal/skill","topology":"/api/articles/nad-plus-trigeminal/topology","versions":"/api/articles/nad-plus-trigeminal/revisions","invocations":"/api/articles/nad-plus-trigeminal/invocations"},"editorial_review":null,"editorial_audit":{"slug":"nad-plus-trigeminal","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"961a7effb4cabacb17fe5642dee0a99660fdba2f47b4bf33d6573e9381eefcab"}}}